Fiera Capital (Canada)’s Madrigal Pharmaceuticals MDGL Stock Holding History

Fiera Capital (Canada)’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.6M	Sell	99,857 -74,154	-43%	-$38M	0.19%	80
2026 Q1	$91.1M	Buy	174,011 +4,555	+3%	+$2.18M	0.31%	57
2025 Q4	$98.7M	Buy	169,456 +41,656	+33%	+$21.3M	0.31%	55
2025 Q3	$58.6M	Sell	127,800 -2,822	-2%	-$1.05M	0.19%	79
2025 Q2	$39.5M	Sell	130,622 -1,557	-1%	-$464K	0.13%	112
2025 Q1	$43.8M	Buy	132,179 +24,757	+23%	+$8.13M	0.16%	94
2024 Q4	$33.1M	Sell	107,422 -4,458	-4%	-$1.25M	0.1%	124
2024 Q3	$23.7M	Sell	111,880 -3,535	-3%	-$904K	0.07%	146
2024 Q2	$32.3M	Buy	+115,415	New	+$27.5M	0.1%	128

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fiera Capital (Canada)'s MDGL Position: Q2 2026 in Review

Fiera Capital (Canada) reduced its Madrigal Pharmaceuticals (MDGL) stake by 43% in Q2 2026, selling an estimated $38M and leaving 99,857 shares worth $53.6M. The position accounts for 0.19% of the portfolio, ranked #80.

Fiera Capital (Canada) first reported a position in MDGL in Q2 2024 and has held it in 9 quarters since. The position peaked at $98.7M in Q4 2025. 415 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Fiera Capital (Canada) held 99,857 shares of Madrigal Pharmaceuticals worth $53.6M as of Q2 2026.
Fiera Capital (Canada) sold 74,154 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $38M.
Madrigal Pharmaceuticals made up 0.19% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #80 holding.
Fiera Capital (Canada) first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Fiera Capital (Canada)'s Madrigal Pharmaceuticals position peaked at $98.7M in Q4 2025.
415 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.